{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:29:03Z","timestamp":1772188143906,"version":"3.50.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0076298","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T18:55:20Z","timestamp":1380653720000},"page":"e76298","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01386853","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ping-Yen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hsun","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ren","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"J Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","article-title":"Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study","volume":"26","author":"W Lu","year":"2003","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel","year":"2001","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"HM Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"PS Sever","year":"2003","journal-title":"Lancet"},{"key":"ref7","first-page":"251","article-title":"Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison","volume":"52","author":"Y Saito","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0024-3205(02)02038-6","article-title":"HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes","volume":"71","author":"H Sone","year":"2002","journal-title":"Life Sci"},{"key":"ref9","first-page":"745","article-title":"Metabolic fate of pitavastatin (NK-104), a new inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase. Effects on drug-metabolizing systems in rats and humans","volume":"52","author":"H Fujino","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2008.02.008","article-title":"Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study)","volume":"201","author":"K Yokote","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref11","article-title":"12-week, randomized, multicenter, double-blind, active-controlled, non-inferiority study to compare the efficacy and safety of pitavastatin and atorvastatin (High risk hypercholesterolemic patients as efficacy and safety study of pitavastatin and atorvastatin in high risk hypercholesterolemic patients, NCT01386853).","author":"JW Chen","year":"2011"},{"key":"ref12","first-page":"382","article-title":"Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase","volume":"54","author":"H Fujino","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8227(01)00365-5","article-title":"Report of the Committee on the classification and diagnostic criteria of diabetes mellitus","volume":"55","author":"T Kuzuya","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"ref14","first-page":"885","article-title":"Clinical safety and efficacy of NK-104 (Pitavastatin), a new synthetic HMG-CoA reductase inhibitor, in the long-term treatment of hyperlipidemia\u2014results of a multicenter long-term study","volume":"17","author":"T Teramoto","year":"2001","journal-title":"Clin Ther Med"},{"key":"ref15","first-page":"2123","article-title":"Clinical effect of the novel HMG-CoA reductase inhibitor CI-981 (atorvastatin) in long-term treatment","volume":"19","year":"1999","journal-title":"Prog Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2710.2011.01274.x","article-title":"Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia","volume":"37","author":"N Poolsup","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbrc.2004.09.122","article-title":"Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell","volume":"324","author":"T Maejima","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5551\/jat.12.163","article-title":"Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes","volume":"12","author":"A Saiki","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1253\/circj.CJ-10-1163","article-title":"Comparison of preventive effect on cardiovascular events with different statins. \u2212 The CIRCLE study","volume":"75","author":"T Maruyama","year":"2011","journal-title":"Circ J"},{"key":"ref20","first-page":"17","article-title":"High risk for future events in acute stroke patients with an ankle-brachial index less than 0.9","volume":"28","author":"CY Li","year":"2012","journal-title":"Acta Cardiol Sin"},{"key":"ref21","first-page":"145","article-title":"Comparison of in-hospital outcome of acute ST elevation myocardial infarction in patients with versus without diabetes mellitus","volume":"27","author":"HP Hsu","year":"2011","journal-title":"Acta Cardiol Sin"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"PM Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"N Sattar","year":"2010","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2004.01.034","article-title":"Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity","volume":"174","author":"O Hanyu","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2125.2005.02462.x","article-title":"Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin","volume":"60","author":"H Ando","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5551\/jat1994.7.138","article-title":"Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells","volume":"7","author":"S Morikawa","year":"2000","journal-title":"J Atheroscler Thromb"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11745-003-1093-x","article-title":"Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-\/-) mice","volume":"38","author":"T Egawa","year":"2003","journal-title":"Lipids"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0114175","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0076298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:23:37Z","timestamp":1540308217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0076298"}},"subtitle":[],"editor":[{"given":"Stephen\u00a0L","family":"Atkin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0076298","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718133446.793488344","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}